UK markets close in 4 hours 30 minutes

Biogen Inc. (BIIB.SW)

Swiss - Swiss Delayed price. Currency in USD
Add to watchlist
232.000.00 (0.00%)
As of 04:07PM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
9,663,100
9,835,600
10,173,400
10,981,700
13,444,600
-
Cost of revenue
2,412,800
2,533,400
2,278,300
2,109,700
1,805,200
-
Gross profit
7,250,300
7,302,200
7,895,100
8,872,000
11,639,400
-
Operating expenses
Research development
2,344,300
2,462,000
2,231,100
2,501,200
3,990,900
-
Selling general and administrative
2,526,200
2,549,700
2,403,600
2,674,300
2,504,500
-
Total operating expenses
5,366,500
5,471,100
4,993,200
6,064,000
7,193,100
-
Operating income or loss
1,883,800
1,831,100
2,901,900
2,808,000
4,446,300
-
Interest expense
253,600
246,900
246,600
253,600
222,500
-
Total other income/expenses net
-519,900
-563,900
847,200
-820,200
781,700
-
Income before tax
1,323,300
1,296,800
3,591,800
1,745,200
5,047,500
-
Income tax expense
156,000
135,300
632,800
52,500
992,300
-
Income from continuing operations
1,167,300
1,161,500
2,961,600
1,727,600
4,060,500
-
Net income
1,166,600
1,161,100
3,046,900
1,556,100
4,000,600
-
Net income available to common shareholders
1,166,600
1,161,100
3,046,900
1,556,100
4,000,600
-
Basic EPS
-
-
-
-
-
31.47
Diluted EPS
-
-
-
-
-
31.42
Basic average shares
-
-
-
-
-
187,100
Diluted average shares
-
-
-
-
-
187,400